Expert Opinion on Investigational Drugs
|
Abbreviated title (ISO 4)
|
Expert Opin. Investig. Drugs |
|---|---|
| Discipline | Pharmacology |
| Language | English |
| Publication details | |
| Publisher | |
|
Publication history
|
1992-present |
| Frequency | Monthly |
| 5.528 | |
| Indexing | |
| ISSN | 1354-3784 (print) 1744-7658 (web) |
| CODEN | EOIDER |
| OCLC no. | 30379431 |
| Links | |
Expert Opinion on Investigational Drugs is a monthly peer-reviewed medical journal covering developments in pharmaceutical research, from animal studies through to early clinical investigation. The journal's scope includes therapeutics in many areas: pulmonary-allergy, dermatology, gastrointestinal, arthritis, infectious disorders, endocrine and metabolic, central and peripheral nervous system, cardiovascular and renal, and oncology.
The journal is published by Informa and the Editor-in-Chief is Giuseppe Tonini, Director of Medical Oncology, University Campus Bio-Medico, (Italy). Expert Opinion on Investigational Drugs was established in 1992 and according to the Journal Citation Reports has a 2014 impact factor of 5.528. It is also indexed in MEDLINE. The journal is available online and in paper format.
Article categories
The journal publishes articles in the following categories:
- Reviews
- Original Research Papers
- Drug Evaluations
- Meeting Highlights
- Editorials
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about a scientific journal on pharmacology is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
